Dimerix Stock

Dimerix Dividend

Dividend of Dimerix (DXB.AX) as of Jul 25, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does Dimerix 2026 pay?

According to the latest status from July 2026, Dimerix paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current Dimerix price of 0.24 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Dimerix Dividends

PaydateDividend
10/24/19990.01AUD
5/16/19990.02AUD
10/16/19980.04AUD

Is the Dimerix Dividend Safe?

Dimerix has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Dimerix's Dividend Distributions

Dimerix’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Dimerix's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Dimerix's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Dimerix’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Dimerix paid dividends every year for the past 0 years.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Dimerix